TY - JOUR
T1 - Article Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo
AU - Hasaart, Karlijn A L
AU - Manders, Freek
AU - Ubels, Joske
AU - Verheul, Mark
AU - van Roosmalen, Markus J
AU - Groenen, Niels M
AU - Oka, Rurika
AU - Kuijk, Ewart
AU - Lopes, Susana M Chuva de Sousa
AU - Boxtel, Ruben van
N1 - Funding Information:
We would like to thank Arianne Brandsma for providing feedback on our manuscript and the FACS and Imaging facility of the Princess Máxima Center for Pediatric Oncology for their support. This study was financially supported by a VIDI grant from the Netherlands Organisation for Scientific Research (NWO no. 016.Vidi.171.023) to R.v.B. and a grant from the Dutch Cancer Society (KWF no. 11307) to R.v.B. and S.M.C.d.S.L. K.A.L.H. performed sample preparation, FACS, RNA isolation, and ISC and HSPC cultures. K.A.L.H. and M.V. performed iPSC culture and DNA isolations. K.A.L.H. and N.M.G. performed EdU-PH3 stainings. M.V. performed library preparation and capture for targeted deep sequencing. E.K. generated iPSC cultures. K.A.L.H. F.M. J.U. M.J.v.R, and R.O. performed bioinformatic analyses. S.M.C.d.S.L collected fetal material. K.A.L.H. and R.B. wrote the manuscript. R.B. designed and supervised the study. All authors reviewed the manuscript. The authors declare no competing interests.
Funding Information:
We would like to thank Arianne Brandsma for providing feedback on our manuscript and the FACS and Imaging facility of the Princess Máxima Center for Pediatric Oncology for their support. This study was financially supported by a VIDI grant from the Netherlands Organisation for Scientific Research (NWO no. 016.Vidi.171.023) to R.v.B. and a grant from the Dutch Cancer Society (KWF no. 11307) to R.v.B. and S.M.C.d.S.L.
Publisher Copyright:
© 2022 The Authors
PY - 2022/2/18
Y1 - 2022/2/18
N2 - Induced pluripotent stem cells (iPSCs) hold great promise for regenerative medicine, but genetic instability is a major concern. Embryonic pluripotent cells also accumulate mutations during early development, but how this relates to the mutation burden in iPSCs remains unknown. Here, we directly compared the mutation burden of cultured iPSCs with their isogenic embryonic cells during human embryogenesis. We generated developmental lineage trees of human fetuses by phylogenetic inference from somatic mutations in the genomes of multiple stem cells, which were derived from different germ layers. Using this approach, we characterized the mutations acquired pre-gastrulation and found a rate of 1.65 mutations per cell division. When cultured in hypoxic conditions, iPSCs generated from fetal stem cells of the assessed fetuses displayed a similar mutation rate and spectrum. Our results show that iPSCs maintain a genomic integrity during culture at a similar degree as their pluripotent counterparts do in vivo.
AB - Induced pluripotent stem cells (iPSCs) hold great promise for regenerative medicine, but genetic instability is a major concern. Embryonic pluripotent cells also accumulate mutations during early development, but how this relates to the mutation burden in iPSCs remains unknown. Here, we directly compared the mutation burden of cultured iPSCs with their isogenic embryonic cells during human embryogenesis. We generated developmental lineage trees of human fetuses by phylogenetic inference from somatic mutations in the genomes of multiple stem cells, which were derived from different germ layers. Using this approach, we characterized the mutations acquired pre-gastrulation and found a rate of 1.65 mutations per cell division. When cultured in hypoxic conditions, iPSCs generated from fetal stem cells of the assessed fetuses displayed a similar mutation rate and spectrum. Our results show that iPSCs maintain a genomic integrity during culture at a similar degree as their pluripotent counterparts do in vivo.
KW - Cell biology
KW - Genomics
KW - Stem cells research
UR - http://www.scopus.com/inward/record.url?scp=85123215342&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2022.103736
DO - 10.1016/j.isci.2022.103736
M3 - Article
C2 - 35118356
VL - 25
JO - iScience
JF - iScience
IS - 2
M1 - 103736
ER -